World Wide Patents

This phased roll out will expand US Orange Book branded products with unexpired patents to global coverage. This new addition will speed the process of due diligence from weeks to hours. Subscribers can now identify opportunities for generic entry outside of the US and access the risk of competitive products.

Subscribers will possess the ability to search by:
• Country
• Therapeutic Indication
• Chemical Biological Class
• Active Ingredient
• US Patent Number
• Filing Date
• Family Parent with Legal Status
• And many more!

The types of information found:
• Orange Book Data
• Chemistry
• Abstracts
• Bibliography
• AIP News

R&D Spend Data

We've expanded the current R&D spend data to now include evaluating R&D spending verses other key metrics such as sales and marketing.

Subscribers can now track the competition, justify R&D budgets, find any soft spots in the industry where there might not be enough spending on research, and screen potential acquisitions. Subscribers now have the opportunity to make comparisons on over 1,000 US public companies regarding their R&D spending and intensity.

The types of information in this feature includes: R&D spending, R&D intensity, as well as sales.

Molecule Track

This tool allows searching by product name as well as active ingredient and associated synonyms.

With this enhanced search feature, subscribers can make specific competitive searches and also have the ability to view various indications in which each active ingredient is being developed. It covers all areas such as company, pipeline, and the Disease Hub

The active ingredient search can be found in the Disease Hub, Competitive Products, Extended Product Profiles, Milestones, Patents, and on the homepage.

We will also launch an enhanced Management Contact Screener allowing for flexible searches on name, company, position, or geographic location.